Riskpilot← Back to searchSign inGet full accessPurakliniken AB
ABActiveOrg 5592784192Roslagsgatan 42Beauty care and other beauty treatment activities · NACE 9622Est. 20205 employees
Revenue 2025
SEK 8,7M
+45% vs 2024
EBITDA margin
-0.9%
-113% vs 2024
Equity ratio
20.4%
Financial strength
Net profit 2025
SEK -304K
-198% vs 2024
| Revenue | SEK 8,7M | +45% |
| EBITDA | SEK -77K | -113% |
| Net profit | SEK -304K | -198% |
| Total assets | SEK 2,3M | +32% |
| Equity | SEK 475K | -39% |
| Employees | 5 | — |
Legal name
Purakliniken AB
Org number
5592784192
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
23 oktober 2020
Share capital
SEK 25 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Purasell, Daniel Purasell, Mino Fatemeh Styrelsen ska bestå av 3 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Föremålet för bolagets verksamhet är tandvård, estetisk medicin, värdepappershandel, handel och förvaltning av fastigheter och därmed förenlig verksamhet.
Address
Roslagsgatan 42
Email
daniel@purakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 520 | 4 647 | 4 282 | 6 041 | 8 748 |
| Staff expenses | — | — | — | — | −2 889 |
| EBITDA | −238 | 404 | 464 | 595 | −77 |
| Depreciation & amort. | −41 | −190 | −190 | −191 | −218 |
| EBIT | −279 | 214 | 274 | 404 | −294 |
| Net financials | −1 | −2 | −2 | −3 | −9 |
| Profit before tax | −280 | 213 | 272 | 401 | −304 |
| Tax | −0 | −0 | −60 | −92 | — |
| Net profit | −280 | 213 | 212 | 309 | −304 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 424 | 1 230 | 1 227 | 1 766 | 2 325 |
| Equity | 45 | 258 | 470 | 779 | 475 |
| Long-term debt | 0 | 0 | 0 | 0 | 667 |
| Short-term debt | 1 379 | 972 | 757 | 987 | 1 183 |
| Total debt | 1 379 | 972 | 757 | 987 | 1 850 |
EBITDA margin
-0.9%
This company
15.8%
Market median
-106% vs market
20212025
Equity ratio
20.4%
This company
38.2%
Market median
-47% vs market
20212025
Return on equity
-63.9%
This company
18.4%
Market median
-447% vs market
20212025
Net profit margin
-3.5%
This company
8.1%
Market median
-143% vs market
20212025
Asset turnover
3.76×
This company
1.12×
Market median
+236% vs market
20212025
Debt / equity
3.89×
This company
0.62×
Market median
-527% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Chairman | 2025 | |
| Former (1) | ||
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Purakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tommy Elias Amour | Board of Directors | 0 companies |
| Mino Fatemeh Purasell | Board of Directors | 0 companies |
| Michael Purasell | Deputy Board Member | 0 companies |
| Daniel Purasell | Chairman | 0 companies |